Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Hemasphere
|
November 15, 2019
Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group
Andreas Engert, Helen Goergen, Jana Markova, et al.
Blood
|
May 31, 2023
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies
Dennis A Eichenauer, Ina Bühnen, Christian Baues, et al.
Hemasphere
|
June 25, 2026
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up
Dennis A Eichenauer, Marc André, Peter Borchmann, et al.
Haematologica
|
September 16, 2017
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials
Dennis A Eichenauer, Ingrid Becker, Ina Monsef, et al.
British Journal of Haematology
|
November 14, 2021
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)
Sarah Gillessen, Andreas Hüttmann, Vladan Vucinic, et al.
British Journal of Haematology
|
August 28, 2015
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
Paul J Bröckelmann, Helen Goergen, Michael Fuchs, et al.
American Journal of Hematology
|
October 29, 2025
Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis
Lucas Kühne, Linus A Völker, Ulf Schönermarck, et al.
Annals of Hematology
|
May 10, 2025
Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry
Anthea Storck, Gernot Beutel, Matthias Kochanek, et al.
Nature Communications
|
May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
Lorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2026
Management of critically ill cancer patients. Expert consensus statement of the "Intensive Care for Hematology and Oncology Patients" (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN)
Asterios Tzalavras, Elena Busch, Boris Böll, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Hemasphere
|
November 15, 2019
Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group
Andreas Engert, Helen Goergen, Jana Markova, et al.
Blood
|
May 31, 2023
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies
Dennis A Eichenauer, Ina Bühnen, Christian Baues, et al.
Hemasphere
|
June 25, 2026
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up
Dennis A Eichenauer, Marc André, Peter Borchmann, et al.
Haematologica
|
September 16, 2017
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials
Dennis A Eichenauer, Ingrid Becker, Ina Monsef, et al.
British Journal of Haematology
|
November 14, 2021
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)
Sarah Gillessen, Andreas Hüttmann, Vladan Vucinic, et al.
British Journal of Haematology
|
August 28, 2015
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
Paul J Bröckelmann, Helen Goergen, Michael Fuchs, et al.
American Journal of Hematology
|
October 29, 2025
Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis
Lucas Kühne, Linus A Völker, Ulf Schönermarck, et al.
Annals of Hematology
|
May 10, 2025
Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry
Anthea Storck, Gernot Beutel, Matthias Kochanek, et al.
Nature Communications
|
May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
Lorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2026
Management of critically ill cancer patients. Expert consensus statement of the "Intensive Care for Hematology and Oncology Patients" (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN)
Asterios Tzalavras, Elena Busch, Boris Böll, et al.
Page
of 11